| Prof David J Powner, MD | |
|
6410 Fannin St, 1020, Houston, TX 77030-3000 | |
| (832) 325-7090 | |
| (713) 512-2238 |
| Full Name | Prof David J Powner |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 6410 Fannin St, Houston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417996356 | NPI | - | NPPES |
| 049266202 | Medicaid | TX | |
| 049266203 | Medicaid | TX | |
| 8AR789 | Other | TX | BCBSTX |
| 8B8792 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | L6584 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Prof David J Powner, MD Po Box 201088, Houston, TX 77216-1088 Ph: (713) 500-3500 | Prof David J Powner, MD 6410 Fannin St, 1020, Houston, TX 77030-3000 Ph: (832) 325-7090 |
News Archive
In influencing the trajectory of the pandemic stage of an emerging pathogen, a population's susceptibility to a novel disease is more influential than climate factors like humidity.
Diamyd completed screening for US Phase III study in type 1 diabetes. The screening of patients for the US Phase III study, DiaPrevent, was completed, ending the recruitment campaign. More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age had, at the completion of screening, been enrolled in the study and received their first injection of the antigen-based therapy Diamyd® or placebo.
Lexicon Pharmaceuticals, Inc., today reported financial results for the second quarter ended June 30, 2015 and provided an overview of key milestones for the company's lead drug candidates.
A new study has found a link between the activity levels of elderly people who have just been released from the hospital and the risk that they will require readmission within 30 days.
​Investigators at the Cedars-Sinai Regenerative Medicine Institute have discovered eye abnormalities that may help reveal features of early-stage Alzheimer's disease. Using a novel laboratory rat model of Alzheimer's disease and high-resolution imaging techniques, researchers correlated variations of the eye structure, to identify initial indicators of the disease.
› Verified 3 days ago
Dr. Michaela Elizabeth Ginn, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 13214 Indian Creek Road, Houston, TX 77079 Phone: 713-591-3555 Fax: 661-321-3286 | |
Ameena Bagree Malhotra, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, 77030-4009, Houston, TX 77030 Phone: 713-792-6161 | |
Svetang Vijay Desai, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 Fm 1959 Rd, Suite A, Houston, TX 77034 Phone: 281-481-9400 | |
Dr. Stalin R Subramanian, M.D Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 7200 Cambridge St Fl 8, Houston, TX 77030 Phone: 713-798-0950 | |
Robin Boliver-campbell, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 7141 Southwest Fwy, Houston, TX 77074 Phone: 713-771-7921 Fax: 713-264-8659 | |
Henna Mukhtar Malik, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 13215 Dotson Rd Ste 300, Houston, TX 77070 Phone: 281-894-8822 | |
Zaven Sargsyan, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1504 Taub Loop, Houston, TX 77030 Phone: 713-873-8890 |